Name
Dealmaking, pipelines, and regulatory risk – the current life sciences M&A landscape
Date & Time
Wednesday, October 21, 2026, 10:45 AM - 11:45 AM
Speakers
Description
- The resurgence of life sciences dealmaking in 2026, and the drivers behind renewed M&A activity
- Agency scrutiny of transactions involving pipeline products and future competition
- What the shift from transformative “megadeals” to targeted acquisitions of specialised firms means for the future of M&A deals
Session Type
Panel